셀트리온제약

068760KOSDAQ의약품 제조업

54.8 / 100

Reference Date: 2026-07-24

Financial Score20.5 / 40

News Sentiment18.3 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: ROE significantly exceeds the industry average but PER raises overvaluation concerns. Declined 5.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Celltrion Pharma is a pharmaceutical company with KGMP, U.S. cGMP, and EU-GMP certifications, producing specialty and biopharmaceuticals at facilities in Jincheon and Ochang, South Korea. Key products include the liver disease treatment 'Godeks' and biosimilars such as 'Ramsima', 'Omlizumab', 'Stelizumab', and 'Aducanumab'. Sales in 2024 rose 22.9% year-on-year to 4.778 trillion KRW.

Number of Employees

1,006people

Average Salary

77.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

43.78Industry Average 11.230.0Point

3.9x industry avg (risky)

PBR

3.98Industry Average 0.810.0Point

4.9x industry avg (risky)

ROE

9.31Industry Average 4.017.0Point

2.3x industry avg (excellent)

Debt Ratio

9.14Industry Average 12.435.0Point

Lower than industry avg (good)

Trend 2023~20258.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.6% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲26.9% (2-year basis)

ROE Trend

3.0 / 4

Avg ROE 6.9% (improving, 3yr)

Detailed News Sentiment

15 totalPositive 10Neutral 5Negative 0Average Sentiment Score 73.3

Positive
[단독] "연봉 5% 더 얹고 육아휴직 2년"…'승부사' 서정진의 통큰...
셀트리온제약의 서정진 회장이 전 직원 급여 인상과 강화된 복리후생 정책을 발표하여 직원 만족도와 동기 부여를 높일 것으로 기대됩니다.
Positive
2兆 투자 앞둔 셀트리온제약…SC 허브 꿈 꾸는데 ‘첫 노조’ 깃발
셀트리온제약의 대규모 투자로 PFS 생산능력 강화와 첫 노동조합 출범으로 인력 관리 개선 기대, 경쟁력 강화 전망.
Positive
“충북에 102조 투자”…부지부터 전력·용수까지 전폭 지원 채비
셀트리온제약의 충북 투자 유치에 따른 대규모 인프라 지원으로 기업 성장 기대감 증가.

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 39,050Won52-week high 75,70052-week low 38,000

1-month return2.0Point

1m -5.68% (slight drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral장래사업ㆍ경영계획(공정공시)2026-07-02